Richard Maclennan

Trainee Patent Attorney

BSc (Hons), PhD

Richard’s experience in patents, but also from working in industry and academia, helps him to understand his clients’ priorities. As part of Horizon 2020, the biggest-ever EU research and innovation programme, Richard gained insight into the challenges faced by a range of organisations.

Richard’s work involves drafting and prosecuting patent applications for biotechnology and life science inventions. He also has experience with  potential revocation action in the UK.

Richard’s practice covers a range of technologies including molecular biology applications such as next generation sequencing and gene editing. He also has experience with improved pharmaceutical compositions, second medical uses for known compounds and novel treatment regimens and methods.

Richard graduated with a degree in Molecular Medicine from the University of Sussex and has a PhD in Molecular Toxicology from the University of Nottingham. His research experience includes cell cycle checkpoint control in response to DNA damage, 3D cell culture systems for maintenance of primary cell phenotype, microarray and next generation sequencing and support for in-silico modelling of complex biological systems.

AREAS OF PRACTICE IN PATENTS:

• Agriscience
• Anti-infectives
• Antibodies
• Biologics
• Diagnostic methods and tools
• Gene editing
• Gene therapy
• Genetic engineering
• Genomics
• Industrial biotechnology
• Medical treatment regimes
• Molecular biology
• Oncology
• Personalised medicine
• Pharmaceuticals
• Pharmaceutical packaging
• Protein biochemistry
• RNA interference
• Supplementary Protection Certificates (SPCs)